Sort
21,453 grants matching “tuberculosis”
Development and Manufacture of Adjuvants for Vaccines Targeting MDR Tuberculosis
$979,306Rhea N Coler · Access To Advanced Health Institute · U01 · FY2008 · AI
Development and Formulation of Broad Spectrum Antimicrobials for Biodefense
$979,210Richard A Slayden · Colorado State University · U01 · FY2009 · AI
Development and Formulation of Broad Spectrum Antimicrobials for Biodefense
$978,895Richard A Slayden · Colorado State University · U01 · FY2010 · AI
Immunotherapeutic approach for the prevention of secondary infection with drug-resistant TB
$978,349Rhea N Coler · Seattle Children'S Hospital · R01 · FY2025 · AI
Immunotherapeutic approach for the prevention of secondary infection with drug-resistant TB
$978,338Rhea N Coler · Seattle Children'S Hospital · R01 · FY2024 · AI
Host Determinants of TB Disease Progression
$978,239Alan A Aderem · Seattle Biomedical Research Institute · U19 · FY2015 · AI
Peptide-based ELISA for laboratory diagnosis of sarcoidosis
$978,191Andrew E. Levin · Kephera Diagnostics, Llc · R44 · FY2025 · HL
Oral anti-TNF antibody for inflammatory bowel disease
$978,045Daniel E Tracey · Avaxia Biologics, Inc. · R44 · FY2012 · DK
Tulane National Primate Research Center
$977,475Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2009 · RR
Exploration, conservation, & development of marine biodiversity in Fiji and the S
$977,212Mark E Hay · Georgia Institute Of Technology · U19 · FY2016 · TW
Vaccine Platforms
$976,949Ronald G Crystal · Wadsworth Center · U54 · FY2008 · AI
A CD8+ T cell diagnostic to identify children with pulmonary tuberculosis
$976,910Melissa R Nyendak · Viti, Inc. · R44 · FY2013 · AI
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
$976,790Shabaana A. Khader · Washington University · R01 · FY2018 · AI
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
$976,570Judith S. Currier · University Of California Los Angeles · UM1 · FY2025 · AI
International Clinical Trials Unit
$976,501John A Bartlett · Duke University · U01 · FY2006 · AI
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$975,813Maureen E Murphy · Ohio State Department Of Health · U52 · FY2007 · PS
Immunology and Outcomes after HAART in HIV/TB Coinfection
$975,640Gregory P. Bisson · University Of Pennsylvania · R01 · FY2012 · AI
A CD8+ T cell diagnostic to identify children with pulmonary tuberculosis
$975,202Melissa R Nyendak · Viti, Inc. · R44 · FY2015 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$974,750Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2021 · AI
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children
$974,009Galit Alter · Massachusetts General Hospital · R01 · FY2020 · AI
Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging
$973,384Stanton L Gerson · Case Western Reserve University · U54 · FY2024 · CA
Collaborative Modeling for Assessment and Optimization in Public Health
$973,020Marc Lipsitch · Harvard School Of Public Health · U54 · FY2015 · GM
Emory/Georgia TB Research Advancement Center (TRAC)
$972,285Neel Rajnikant Gandhi · Emory University · P30 · FY2023 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$972,283Neel Rajnikant Gandhi · Emory University · P30 · FY2024 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$972,283Neel Rajnikant Gandhi · Emory University · P30 · FY2025 · AI